HCI Group Reports Fourth Quarter and Full Year 2016 Results
Feb 21, 2017 21:15 pm UTC| Business
TAMPA, Fla., Feb. 21, 2017 -- HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, with additional operations in reinsurance, real estate and information technology, reported results...
La-Z-Boy Reports Fiscal 2017 Third-Quarter Results
Feb 21, 2017 21:15 pm UTC| Business
MONROE, Mich., Feb. 21, 2017 -- La-Z-Boy Incorporated (NYSE:LZB) today reported its operating results for the fiscal 2017 third quarter ended January 28, 2017. Fiscal 2017 third-quarter highlights: The company...
SemGroup Corporation to Participate in Upcoming Conferences
Feb 21, 2017 21:15 pm UTC| Business
TULSA, Okla., Feb. 21, 2017 -- SemGroup® Corporation (NYSE:SEMG) Chief Executive Officer Carlin Conner and Chief Financial Officer Bob Fitzgerald are scheduled to participate in Barclays MLP Corporate Access Day on...
TESARO Announces Participation at Two Investor Conferences
Feb 21, 2017 21:15 pm UTC| Business
WALTHAM, Mass., Feb. 21, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are: The Raymond...
Mattersight to Present at the 29th Annual Roth Conference
Feb 21, 2017 21:15 pm UTC| Business
CHICAGO, Feb. 21, 2017 -- Mattersight Corporation (NASDAQ:MATR), the pioneer in personality-based software applications, today announced that the Company will attend the 29th Annual Roth Conference on March 12-15, 2017...
Sigma Labs Announces Completion of Public Offering and Gross Proceeds of Approximately $5.8 Million
Feb 21, 2017 21:15 pm UTC| Business
SANTA FE, N.M., Feb. 21, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced the closing of its previously...
Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer
Feb 21, 2017 21:10 pm UTC| Business
SAN RAMON, Calif., Feb. 21, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced that the Company’s...